Perspective Therapeutics
CATX · NYSE American
$2.30+$0.11 (+5.02%)TodayMarket closed ·
Prev close $2.19
EPS: actual vs estimate
Beat the estimate in 6 of the last 8 quarters, by 11.8% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.2615 | -$0.22 | +15.9% |
| Q1 FY26 | -$0.3021 | -$0.25 | +17.2% |
| Q4 FY25 | -$0.3636 | -$0.51 | −40.3% |
| Q3 FY25 | -$0.3328 | -$0.35 | −5.2% |
| Q2 FY25 | -$0.3079 | -$0.29 | +5.8% |
| Q1 FY25 | -$0.3134 | -$0.25 | +20.2% |
| Q4 FY24 | -$0.2717 | -$0.25 | +8.0% |
| Q3 FY24 | -$0.2176 | -$0.21 | +3.5% |
Earnings calls
- Bank of America Global Healthcare Conference 2026
- Shareholder/Analyst Call - Perspective Therapeutics, Inc.
- 44th Annual J.P. Morgan Healthcare Conference
- UBS Global Healthcare Conference 2025
- Special Call - Perspective Therapeutics, Inc.
- Barclays 27th Annual Global Healthcare Conference 2025
- 43rd Annual J.P. Morgan Healthcare Conference 2025
- UBS Global Healthcare Conference 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.